Kaiima develops a proprietary Enhanced Ploidy (EP™) technology that multiplies a plant’s genome without compromising its integrity to increase productivity. The company applies EP™ to key crops and energy crops, and has demonstrated the technology in wheat, maize, rapeseed and castor. Kaiima’s stated mission is to help feed and energize the world by introducing new varieties designed for sustainable agriculture with vastly improved yields. Management frames the technology as a yield-enhancement approach distinct from many GM technologies that protect against loss rather than increase yield. The company emphasizes opportunities in emerging markets and plans to leverage investor partnerships to accelerate advances in yield enhancement. Financially, Kaiima completed an equity financing of more than US$65 million.

Total raised

$65M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2013